UiPath Inc.
NYSE:PATHSoftware - Infrastructure
-$0.21 today
- Market cap
- $6.46B
- Beta
- 0.97
- P/E (TTM)
- 16.0
- EPS (TTM)
- $0.63
Volume 23.55M
Average 32.78M
PATH Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
UiPath Inc.NYSE: PATH
Depreciation & Amortization · Q2 FY2027 · quarter ended Jul 2026
Depreciation & amortization growth accelerates
Q2 FY2027 depreciation & amortization of $9.01M rose 112.9% year over year, ahead of the +70.7% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 19.9% from the prior quarter. Over 3 fiscal years it compounded at -3.2% a year.
Context
- Depreciation & amortization amounted to 1.1% of revenue in FY2026, down 0.2 pp from a year earlier.
- Depreciation & amortization increased in 1 of the last 3 fiscal years.
- FY2026 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +112.9% holds above the trailing-twelve-month pace of +70.7%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2026
- 16.97M USD
- Year-over-year change
- -1.5%
- 4-year CAGR
- +3.6%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2026 | 2026-01-31 | 16.97M | -1.5% |
| FY2025 | 2025-01-31 | 17.23M | -23.7% |
| FY2024 | 2024-01-31 | 22.6M | +20.7% |
| FY2023 | 2023-01-31 | 18.72M | +27.3% |
| FY2022 | 2022-01-31 | 14.71M | — |
Depreciation & Amortization vs competitors
How PATH compares with its peers on the latest reported figures
- PATH's LTM Jul 2026 depreciation & amortization of $26M is the 2nd largest of the 4 companies compared; the peer median is $23.7M.
- Its year-over-year change of +70.7% is the 2nd highest of 4, against a peer median of -0.2%.
- Depreciation & amortization amounts to 1.5% of revenue for PATH, versus a peer median of 1.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.07B | +77.6% | +19.5% | 7.3% | |
| LTM Jul 2026 | $26M | +70.7% | -3.2% | 1.5% | |
| LTM Sep 2026 | $23.7M | -41.5% | -9.3% | 1.4% | |
| LTM Sep 2026 | $9.93M | -0.2% | +10.0% | 1.2% | |
| Peer median (excluding PATH) | $23.7M | -0.2% | +10.0% | 1.4% | |
Competitors are the stored peer set for PATH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Jan 2022 | FY2023 Jan 2023 | FY2024 Jan 2024 | FY2025 Jan 2025 | FY2026 Jan 2026 |
|---|---|---|---|---|---|
| Net Income | (525.59M) | (328.35M) | (89.88M) | (73.69M) | 282.33M |
| Depreciation & Amortization | 14.71M | 18.72M | 22.6M | 17.23M | 16.97M |
| Deferred Income Tax | (5.83M) | 861K | 554K | (19.79M) | (202.68M) |
| Stock-Based Compensation | 515.58M | 369.84M | 371.96M | 358.15M | 290.68M |
| Change in Working Capital | (105.9M) | (146.69M) | (66.93M) | (41.77M) | (149.21M) |
| Accounts Receivables | (86.39M) | (123.78M) | (78.91M) | (26.16M) | (22.59M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 3.51M | (1.57M) | (5.05M) | 27.86M | (21.68M) |
| Other Working Capital | (23.02M) | (21.33M) | 17.04M | (43.46M) | (104.94M) |
| Other Non-Cash Items | 52.07M | 75.63M | 60.79M | 80.44M | 133.12M |
| Operating Cash Flow | (54.96M) | (9.98M) | 299.08M | 320.57M | 371.21M |
| Capital Expenditures | (13.06M) | (23.82M) | (7.34M) | (14.92M) | (19.05M) |
| Acquisitions (Net) | (5.5M) | (29.54M) | 0 | (5.57M) | (24.82M) |
| Purchases of Investments | (214.01M) | (388.41M) | (1.49B) | (1.51B) | (772.49M) |
| Sales of Investments | 197.13M | 151.43M | 1.05B | 1.48B | 809.25M |
| Other Investing Activities | 0 | 1.2M | 2.75M | 5.57M | (15.35M) |
| Investing Cash Flow | (35.44M) | (289.14M) | (439.57M) | (45.5M) | (22.47M) |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 692.37M | 23.4M | 24.3M | 23.64M | 15.92M |
| Common Stock Repurchased | 0 | (1.49M) | (102.62M) | (390.75M) | (329.1M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 27.3M | (82.58M) | (118.58M) | (83.4M) | (59.19M) |
| Financing Cash Flow | 1.47B | (60.67M) | (196.9M) | (450.52M) | (372.38M) |
| Effect of Forex Changes | 18.27M | (6.81M) | (2.62M) | (7.03M) | 15.59M |
| Net Change in Cash | 1.4B | (366.6M) | (340M) | (182.48M) | (8.04M) |
| Free Cash Flow | (68.02M) | (33.8M) | 291.74M | 305.64M | 352.16M |
UiPath Inc.
NYSE:PATH
Intrinsic Alpha fair value
Locked
Current Price
$12.39
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.